Search results
GT Medical and Theragenics team up to expand access to radiotherapy seeds
Medical Device Network via Yahoo Finance· 4 hours agoCesium-131 is a common isotope used with low dose rate (LDR) brachytherapy, a radiation treatment...
Novartis to buy radiology drug specialist Mariana for $1 billion
Reuters via AOL· 3 hours agoNovartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront,...
Trelstar dosage: Form, strengths, how to use, and more
Medical News Today· 1 day agoTrelstar (triptorelin pamoate) is a brand-name drug that’s prescribed for advanced prostate cancer...
New Trials in Prostate Cancer: Could Your Patient Benefit?
Medscape· 3 days agoPerhaps one of your patients could benefit from a clinical trial that has recently opened in ...
Keeping cancer in its place: overcoming metastasis
Nature· 7 hours agoMost progress in cancer outcomes over recent decades has been driven by earlier detection and diagnosis, combined with therapies that slow the growth of...
Novartis further entrenches into radiopharma with $1B Mariana buy
FierceBiotech· 4 hours agoWith much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep...
You Can Test Your Blood for 50 Kinds of Cancer
The Atlantic· 51 minutes agoIt takes a certain amount of confidence to call your biotech company Grail. According to its website, the Menlo Park–based firm got its name because its “co-founders believed a simple blood ...
Men on hair-loss drug warned of sexual and psychiatric side effects
The Telegraph via Yahoo News· 3 days agoIt has also ordered suppliers of finasteride to now include a patient alert card in packs of the ...
Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last?
Zacks via Yahoo Finance· 7 hours agoXencor (XNCR) witnessed a jump in share price last session on above-average trading volume. The...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 1 day agoSource: Global Cancer Observatory. Analysts forecast Novartis' second-quarter earnings per share to be between $1.78 and $1.84, remaining almost...
